Covid-19: CFTRI conducts Phase-2 study on sero-surveillance
Coronavirus Update, COVID-19, News

Covid-19: CFTRI conducts Phase-2 study on sero-surveillance

February 18, 2021

Mysore/Mysuru: In continuation of Covid-19 related activities, the CSIR-Central Food Technological Research Institute (CFTRI) has conducted Phase-2 pan-CSIR study on sero-surveillance. 

The study was conducted in collaboration with CSIR- Institute of Genomics and Integrative Biology (IGIB), New Delhi. 

The study aimed at covering the large population size across CSIR laboratories pan India to assess the sustained immune status of an individual and the extent of herd immunity achieved. 

The outcome of the study shall help in formulating Covid-19 vaccine guidelines across the country. 

This phenome India pan-CSIR sero-surveillance was conducted over a period of four days from Feb.4 in the Institute, and open to all CFTRI students, staff and their family members. 

The programme was inaugurated by Dr. Sridevi Annapurna Singh, Director, CSIR-CFTRI. 

Project leader Dr. Prakash M. Halami and members Dr. S.P. Muthukumar, Dr. P.V. Ravindra and Dr. M. Gopinath, Dr. Avilash S. Rani (CFTRI Doctor) and volunteers were present. 

ABOUT

Mysuru’s favorite and largest circulated English evening daily has kept the citizens of Mysuru informed and entertained since 1978. Over the past 41 years, Star of Mysore has been the newspaper that Mysureans reach for every evening to know about the happenings in Mysuru city. The newspaper has feature rich articles and dedicated pages targeted at readers across the demographic spectrum of Mysuru city. With a readership of over 2,50,000 Star of Mysore has been the best connection between it’s readers and their leaders; between advertisers and customers; between Mysuru and Mysureans.

CONTACT

Academy News Papers Private Limited, Publishers, Star of Mysore & Mysuru Mithra, 15-C, Industrial ‘A’ Layout, Bannimantap, Mysuru-570015. Phone no. – 0821 249 6520

To advertise on Star of Mysore, email us at

Online Edition: [email protected]
Print Editon: [email protected]
For News/Press Release: [email protected]